MediSix Therapeutics Company
Singapore immune cell engineering company using its PEBL platform to build CAR-T therapies for T-cell malignancies; founded by Prof Dario Campana, now an IASO Biotechnology subsidiary.
Technology:
Gene Therapies (Diseases Treatment)
Founded Date:
2016-01-01
Industry:
Advanced BioTech R&D
Sub-Industry:
Gene Therapies (Diseases Treatment)
Investors:
ClavystBio
City:
Singapore
Country:
Singapore
